Thurfjell Niklas, Coates Philip J, Uusitalo Tony, Mahani David, Dabelsteen Erik, Dahlqvist Ake, Sjöström Björn, Roos Göran, Nylander Karin
Department of Medical Biosciences/Pathology, Umeå University, SE-901 85 Umeå, Sweden.
Int J Oncol. 2004 Jul;25(1):27-35.
The human p63 gene encodes a series of protein isoforms that differ in their N- and/or C-terminal sequences and possess widely varying activities in promoting or repressing p53-related functions and in regulating the proliferation and differentiation of epithelial cells. To gain further information on the role of p63 expression in human tumours, we used quantitative real-time RT-PCR to study individual p63 isoforms in squamous cell carcinomas of the head and neck (SCCHN). In keeping with previous reports, expression of the deltaN- and p63alpha-isoforms predominated and deltaNp63 mRNA was expressed at significantly higher levels in tumours compared to matched normal tissues. Some tumours also expressed the highly efficient transactivator TA- and p63beta-isoforms, and p63beta was significantly increased in tumours compared to matched normal tissue. We could not identify any correlations between different p63-isoform expression patterns and proliferation, p53 status, or telomerase expression. All p63 isoforms could be identified in normal surface epithelium, and micro-dissection showed that the high levels present in basal layers were similar to those seen in tumour tissues. Thus, high-level expression of deltaNp63 in tumour cells may represent maintained expression by the basal cells from which the tumour arose, rather than representing a true over-expression of p63 during tumourigenesis. Tobacco usage, a genotoxic predisposing factor for SCCHN, had no effect on p63 expression in oral epithelium. Taken together, our data indicate that SCCHN maintain expression of high levels of deltaNp63alpha in combination with varying levels of other p63 isoforms, some of which are highly efficient transcriptional activators. The complexity of these p63 expression patterns seen in primary SCCHN indicates that p63 has multifaceted roles in tumour biology.
人类p63基因编码一系列蛋白质异构体,这些异构体的N端和/或C端序列不同,在促进或抑制p53相关功能以及调节上皮细胞的增殖和分化方面具有广泛不同的活性。为了进一步了解p63表达在人类肿瘤中的作用,我们使用定量实时逆转录聚合酶链反应(RT-PCR)研究头颈部鳞状细胞癌(SCCHN)中的各个p63异构体。与先前的报道一致,δN-和p63α-异构体的表达占主导地位,与匹配的正常组织相比,肿瘤中δNp63 mRNA的表达水平显著更高。一些肿瘤还表达高效反式激活因子TA-和p63β-异构体,与匹配的正常组织相比,肿瘤中p63β显著增加。我们未能发现不同p63异构体表达模式与增殖、p53状态或端粒酶表达之间的任何相关性。在正常表面上皮中可以鉴定出所有p63异构体,显微切割显示基底层中存在的高水平与肿瘤组织中所见的相似。因此,肿瘤细胞中δNp63的高水平表达可能代表肿瘤起源的基底细胞维持的表达,而不是肿瘤发生过程中p63的真正过表达。烟草使用是SCCHN的一种遗传毒性易感因素,对口腔上皮中的p63表达没有影响。综上所述,我们的数据表明,SCCHN维持高水平δNp63α与不同水平的其他p63异构体的表达,其中一些是高效转录激活因子。在原发性SCCHN中看到的这些p63表达模式的复杂性表明p63在肿瘤生物学中具有多方面的作用。